drugset
drugset / Trial / NCT02309008

A Study to Assess the Safety, Tolerability and Pharmacokinetics of PAC-14028 Cream in Healthy Male Subjects

NCT02309008 ↗

Phase 1 Completed 24 enrolled Amorepacific Corporation Seoul National University Hospital · collab
RandomizedParallel-groupDouble-blind

Summary

The purpose of this study is to investigate the safety/tolerability and pharmacokinetics of PAC-14028 cream after transdermal administration in healthy male volunteers.

Timeline

Start
2014-11
Primary completion
2016-04
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject PAC-14028 Unknown 0.1 % Topical
Subject PAC-14028 Unknown 0.3 % Topical
Subject PAC-14028 Unknown 1 % Topical

Indications

No indication recorded.